| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.09 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |